{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:16:04Z","timestamp":1775571364001,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15797-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:14:49Z","timestamp":1772273689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Celldetect test performance in monitoring bladder cancer recurrence after transurethral resection"],"prefix":"10.1186","volume":"26","author":[{"given":"Wen-bo","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"15797_CR1","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1007\/s00261-024-04235-6","volume":"49","author":"SA Khwaja","year":"2024","unstructured":"Khwaja SA, Caglic I, Shaida N, Colquhoun AJ, Turner W, Barrett T. Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT). Abdom Radiol. 2024;49:2340\u20138.","journal-title":"Abdom Radiol"},{"key":"15797_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12672-024-01452-9","volume":"15","author":"W Gao","year":"2024","unstructured":"Gao W. Current opinions regarding the clinical utility of en bloc resection in the treatment of non-muscle invasive bladder cancer\u2014a review of the literature. Discov Oncol. 2024;15:574\u201381.","journal-title":"Discov Oncol"},{"key":"15797_CR3","doi-asserted-by":"crossref","unstructured":"Pierconti F, Martini M, Fiorentino V, Cenci T, Capodimonti S, Straccia P et al. The combination cytology\/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? Urol. Oncol. Semin. Orig. Investig. 2021, 39, 131.e17-131.e21.","DOI":"10.1016\/j.urolonc.2020.06.018"},{"key":"15797_CR4","doi-asserted-by":"publisher","first-page":"29099","DOI":"10.1038\/s41598-024-80705-7","volume":"14","author":"W Gao","year":"2024","unstructured":"Gao W, Lou Z. Single center evaluation of sensitivity and specificity of CellDetect assay in early bladder cancer patients. Sci Rep. 2024;14:29099\u2013109.","journal-title":"Sci Rep"},{"key":"15797_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.euo.2025.04.020","volume":"8","author":"BJ Schmitz-Dr\u00e4ger","year":"2025","unstructured":"Schmitz-Dr\u00e4ger BJ, Bismarck E, Roghmann F, von Landenberg N, Noldus J, Jahn D, et al. Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low\/Intermediate-risk Bladder Cancer. Eur Urol Oncol. 2025;8:1041\u20139.","journal-title":"Eur Urol Oncol"},{"key":"15797_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/cncy.22246","volume":"128","author":"E Trenti","year":"2020","unstructured":"Trenti E, Pycha S, Mian C, Schwienbacher C, Hanspeter E, Kafka M, et al. Comparison of 2 new real-time polymerase chain reaction\u2013based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer. Cancer Cytopathol. 2020;128:341\u20137.","journal-title":"Cancer Cytopathol"},{"key":"15797_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eururo.2025.03.018","volume":"88","author":"T Dreyer","year":"2025","unstructured":"Dreyer T, Brandt S, Fabrin K, Azawi N, V\u00e1squez JL, Ernst A, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non\u2013muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. 2025;88:23\u201330.","journal-title":"Eur Urol"},{"key":"15797_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.euf.2016.10.004","volume":"4","author":"N Davis","year":"2018","unstructured":"Davis N, Shtabsky A, Lew S, Rona R, Leibovitch I, Nativ O, et al. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study. Eur Urol Focus. 2018;4:388\u201394.","journal-title":"Eur Urol Focus"},{"key":"15797_CR9","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.juro.2014.06.079","volume":"192","author":"N Davis","year":"2014","unstructured":"Davis N, Mor Y, Idelevich P, Terkieltaub D, Ziv V, Elkeles A, et al. A Novel Urine Cytology Stain for the Detection and Monitoring of Bladder Cancer. J Urol. 2014;192:1628\u201332.","journal-title":"J Urol"},{"key":"15797_CR10","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/diagnostics15172163","volume":"15","author":"F Sanguedolce","year":"2025","unstructured":"Sanguedolce F, Cormio A, Zanelli M, Zizzo M, Palicelli A, Falagario UG, et al. Diagnostic, Prognostic, and Predictive Tissue Biomarkers in Urothelial Carcinoma In Situ: A Narrative Review. Diagnostics. 2025;15:2163\u20139.","journal-title":"Diagnostics"},{"key":"15797_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12935-021-02169-3","volume":"21","author":"D Shang","year":"2021","unstructured":"Shang D, Liu Y, Xu X, Chen Z, Wang D. Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma. Cancer Cell Int. 2021;21:465\u201371.","journal-title":"Cancer Cell Int"},{"key":"15797_CR12","first-page":"e10819","volume":"40","author":"F Pierconti","year":"2022","unstructured":"Pierconti F, Martini M, Cenci T, Fiorentino V, Gianfrancesco LD, Ragonese M, et al. The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma. Urol Oncol Semin Orig Investig. 2022;40:e10819\u201325.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"15797_CR13","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.3390\/cancers15245770","volume":"15","author":"L Scheipner","year":"2023","unstructured":"Scheipner L, Zurl H, Altziebler JV, Pichler GP, Sch\u00f6pfer-Schwab S, Jasarevic S, et al. Charlson\u2013Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer. Cancers. 2023;15:5770\u20136.","journal-title":"Cancers"},{"key":"15797_CR14","doi-asserted-by":"publisher","first-page":"1623198","DOI":"10.3389\/fmed.2025.1623198","volume":"12","author":"W Gao","year":"2025","unstructured":"Gao W, Ye H, Xu Y. Elderly patients undergoing laparoscopic radical cystectomy benefit from dynamic D-dimer measurement in combination with vascular ultrasonography: reduction of VTE risk and improvement of clinical outcomes. Front Med. 2025;12:1623198\u2013205.","journal-title":"Front Med"},{"key":"15797_CR15","doi-asserted-by":"publisher","first-page":"e0040","DOI":"10.5041\/RMMJ.10314","volume":"8","author":"T Clinton","year":"2017","unstructured":"Clinton T, Lotan Y. Review of the Clinical Approaches to the Use of Urine-based Tumor Markers in Bladder Cancer. Rambam Maimonides Med J. 2017;8:e0040\u20135.","journal-title":"Rambam Maimonides Med J"},{"issue":"2","key":"15797_CR16","first-page":"261","volume":"90","author":"Y \u00d6mer","year":"2023","unstructured":"\u00d6mer Y, \u00c7a\u011fatay T, G\u00fclistan G, Emre T, \u00d6mer E. What is the role of CellDetect\u00ae in detecting and monitoring bladder cancer. \u200cUROLOGIA J\u200c. 2023;90(2):261\u20135.","journal-title":"\u200cUROLOGIA J\u200c"},{"key":"15797_CR17","first-page":"15418","volume":"11","author":"C Barrett","year":"2021","unstructured":"Barrett C, Eric K, Ken J, Karl W, Timothy B, Chad P, et al. Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert\u00ae Bladder Cancer Monitor) for surveillance in patients with non-muscle-invasive bladder cancer. BJU Int. 2021;11:15418\u201327.","journal-title":"BJU Int"},{"key":"15797_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13148-016-0303-5","volume":"9","author":"A Feber","year":"2017","unstructured":"Feber A, Dhami P, Dong L, De Winter P, Tan WS, Mart\u00ednez-Fern\u00e1ndez M, et al. UroMark-a urinary biomarker assay for the detection of bladder cancer. Clin Epigenetics. 2017;9:8\u201317.","journal-title":"Clin Epigenetics"},{"key":"15797_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00345-023-04372-5","volume":"41","author":"GM Busetto","year":"2023","unstructured":"Busetto GM, Del Giudice F, Maggi M, et al. Risk-adapted management of non-muscle-invasive bladder cancer: recommendations from the Italian Urological Association. World J Urol. 2023;41:1\u201312.","journal-title":"World J Urol"},{"key":"15797_CR20","first-page":"102","volume":"48","author":"M Finati","year":"2025","unstructured":"Finati M, Brassetti A, Proietti F, et al. Bladder-preserving strategies after BCG failure in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Open Sci. 2025;48:102\u201315.","journal-title":"Eur Urol Open Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15797-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:33:10Z","timestamp":1775568790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15797-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15797"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15797-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki. The study protocol was approved by the Medical Ethics Committee of Ningbo Urology and Nephrology Hospital. Informed consent was obtained from all individual participants included in the study. Patient data were anonymized to ensure confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}